Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.
about
Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactionsPoxvirus cell entry: how many proteins does it take?Whole cell cryo-electron tomography reveals distinct disassembly intermediates of vaccinia virusA kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamicsVaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion exportIntracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesisRegulation of Macropinocytosis by Diacylglycerol Kinase ζVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansDrosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcriptionExpression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVAVaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replicationA differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cellsVaccinia virus exhibits cell-type-dependent entry characteristics.In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsEntry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.Ligand-induced and nonfusogenic dissolution of a viral membrane.Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes.Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.Identification of Toll-like receptor 9 as parapoxvirus ovis-sensing receptor in plasmacytoid dendritic cellsLipid membranes in poxvirus replication.Vaccinia virus protein complex F12/E2 interacts with kinesin light chain isoform 2 to engage the kinesin-1 motor complexSkin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes.Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pHAssociation of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.Two distinct low-pH steps promote entry of vaccinia virus.Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cellsOrthopoxvirus species and strain differences in cell entry.Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-Glucose
P2860
Q21245114-079CD829-1F5C-4F20-BC89-D8B6D4FE044CQ27002455-2AF7BF9B-60A3-4836-B134-ACEEE605D91EQ27303005-9AF8E3CE-8BC8-4AD3-8643-067A140BE24CQ27314508-A4D8E34F-FC94-4A31-A90F-B21DE1266741Q27315837-2C601E05-0F7A-43F0-88ED-3AC9113641F7Q27321587-71A4D747-0418-41A4-B185-71BEA74B5750Q27325801-5E14CD33-14B6-4595-8580-E87ED827DC7DQ27335044-F570298E-AA05-4ED9-9A2F-20BFF6382835Q27488704-78AE33B9-0DF3-45FB-ABB8-DEE64999E900Q28477161-AAC21980-57DB-43FE-9B00-0A7934D8E1C7Q28727937-EC9D46A8-E03E-421F-96D7-25A64EF11419Q30540518-09C10537-2D6A-4255-8C86-43EC5EE4E5E9Q33565441-126CAEC1-2CB2-4313-A783-E65C7ED9ABC8Q33698769-3A95624E-657F-4A86-B880-C89E2E78245EQ34017475-CEDA07D4-D47C-45A4-AC9B-B7F59336171AQ34055390-B67B599C-E10F-47E6-8CB8-BC00BBD7F0C1Q34109783-ECBF5EBF-7DA3-438B-AE53-AFA5D2049498Q34233115-170409D8-D527-456F-9599-0048522DB7BBQ34507126-35041B76-39D7-4AAE-A41E-68AF4C020353Q34714569-7A270859-6AD3-4D15-A354-550AC367A3BEQ35024254-158D469F-F1DF-4C6D-A196-EDA92A91F589Q35101363-7CFEBBDA-B6CA-401C-B998-B9F47267F268Q35101454-3A84B371-8B17-43F9-AFB2-E2DD4CC50201Q35235154-CEC5CD8D-4A38-492B-B276-FCB30A517B2EQ35260919-75BF7346-ECDE-4548-9C58-471E431041D8Q35575087-ED10D703-92E4-4B92-9763-5C2C8CACFFDAQ35629472-82D2D5A3-7F45-43D1-B62C-3BB85B34EDC4Q35642108-C62999E5-612A-4FDF-95EC-9AFD1081330FQ35784794-0A246715-9E48-4D57-8466-5BEE71F011F6Q35826881-F722D8EF-85FF-4601-A490-7CB213699411Q35857238-0697F40D-8D1A-4C7E-8990-990B667A9A2EQ35943686-E516808C-87D4-4460-90B1-1296DE505073Q35947676-2DA57C5F-D037-4ECC-B3E1-91A5528D16FFQ36098912-CF7B22CE-2A28-41ED-93DB-616473A18F69Q36103310-AF318C6A-6F79-40FE-9785-E8CA946BFE5DQ36315941-3368322D-ACF4-4BEF-A342-A606718205A2Q36673363-D7433B99-F0EB-4213-B658-8A5E2B30BAEEQ36747975-C5F5F3E1-3F35-4019-AFF4-F8649EBB765DQ36845650-F8D3E1A0-FA80-44AB-A65F-174CE20D59E8Q36878858-160D54F2-838C-4E44-B05E-EE9B22F077A5
P2860
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Entry of the vaccinia virus in ...... tions with glycosaminoglycans.
@en
type
label
Entry of the vaccinia virus in ...... tions with glycosaminoglycans.
@en
prefLabel
Entry of the vaccinia virus in ...... tions with glycosaminoglycans.
@en
P2093
P356
P1476
Entry of the vaccinia virus in ...... tions with glycosaminoglycans.
@en
P2093
Gemma C Carter
Geoffrey L Smith
Mansun Law
Michael Hollinshead
P304
P356
10.1099/VIR.0.80831-0
P407
P577
2005-05-01T00:00:00Z